Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 14, 2015; 21(38): 10811-10823
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10811
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10811
European regions | The most prevalent genotype | Other genotypes | Comments | First author |
Northern Europe | 1a | 1b, 2, 4 | G1a frequent among PWID | Bruggmann et al[52], 2014 |
Western Europe | 1b | 3a (France) | G1b-common in older age groups | Messina et al[43], 2015 |
4a (United Kingdom, The Netherlands, Germany) | Payan et al[53], 2005 | |||
Southern Europe | 1b | 2a, 2b, 2c, 4 | G4 is becoming more frequent | Gower et al[10], 2014 |
Cifuentes et al[54], 2015 | ||||
Eastern Europe | 1a | 1b, 2, 3, 4 | Non G1 genotypes reported in migrants | Cornberg et al[16], 2011 |
Messina et al[43], 2015 |
- Citation: Ruta S, Cernescu C. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol 2015; 21(38): 10811-10823
- URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10811.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10811